By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Schneider Shorts 13.01.2023 – confidential whitewashing in Australia, hallmarks of fraud in Cell, Nature journals welcome Count Facula and a Greek cheater, with FDA’s new Alzheimer’s drug, a German editor who can’t stop papermilling, an Italian art lover in Ohio, and why Smut Clyde will never get full credit.
Schneider Shorts of 10.06.2022 – why eugenics science is innocent, with a job opening for a medical school dean, a Turkish biomedical con artist charged with murder, a Herbalife shill whitewashed, a supplement scammer celebrated by CNN, plus a proxalutamide retraction, German Alzheimer’s cure, and Peter Wilmshurst vs Big Pharma to reassure you that science is first and foremost a business.
Is the journal Cell Death and Disease a disease itself, parasitised by Chinese paper mills? Can it be cured? Not with this team of doctors on editorial board.
“…Dr. Hetz seems rather to regret that he did not have better tools for editing the figures, so that the undeclared interventions would have gone unnoticed.” – University of Chile investigative report.
Introducing new For Better Science weekly format: Schneider Shorts
“Patients affected with ALS now need to know that we are working for them […] We feel completely motivated and convinced to dedicate our careers to fight ALS.” Claudio Hetz, Photoshop artist.
David Sabatini, remember that story? Well, it seems the conclusions were not affected. I take an ill-informed look at the mTOR signalling research field, to understand how photoshopped data gets to be independently verified by other labs.
Beware of Chinese collaborators bearing gift authorships!
As a young Wunderkind, Josef Penninger discovered the ACE2 receptor. Now he invented the cure for the coronavirus which will work in his hands where Big Pharma failed. He was never found guilty of research misconduct and never retracted a paper. Dr Penninger is a Genius making a COVID-19 vaccine.
Guido Kroemer receives on 8 November 2019 the €1mn Lombardy Award for Healthy Ageing, at La Scala in Milan. And why not, one panel member was Carlo Croce.
For Better Science